{"ORPHApacket":[{"ORPHApacketID":"102724","date":"2019-12-05 22:05:42","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"102724","Name":[{"lang":"en","label":"Acute myeloid leukemia with t(8;21)(q22;q22) translocation"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_102724","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Acute myeloid leukemia with recurrent genetic anomaly"}],"ORPHA":"98277","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_98277"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare acute myeloid leukemia with recurrent genetic anomaly disorder characterized by a t(8;21)(q22;q22) balanced translocation cytogenetic abnormality, forming a RUNX1-RUNX1T1 fusion gene, presenting with morphological characteristics which include myeloblasts with indented nuclei, basophilic cytoplasm with a prominent paranuclear hof that may contain a few azurophilic granules, prominent and possibly large promyelocytes, myelocytes and metamyelocytes, easily identifiable Auer rods and, more variably, bone marrow eosinophilia. Myeloid sarcoma is frequently present at diagnosis. Detection of the t(8;21)(q22;22) translocation is sufficient for diagnosis irrespective of blast count."}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"AML with t(8;21)(q22;q22) translocation"}]}],"DisorderGeneAssociationList":[{"count":"5","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"RUNX family transcription factor 1"}],"Symbol":"RUNX1","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"10471"},{"Source":"OMIM","Reference":"151385"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317348","Name":[{"lang":"en","label":"Part of a fusion gene in"}]}]},{"Gene":[{"Name":[{"lang":"en","label":"fms related tyrosine kinase 3"}],"Symbol":"FLT3","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"3765"},{"Source":"OMIM","Reference":"136351"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"465410","Name":[{"lang":"en","label":"Biomarker tested in"}]}]},{"Gene":[{"Name":[{"lang":"en","label":"CCAAT enhancer binding protein alpha"}],"Symbol":"CEBPA","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"1833"},{"Source":"OMIM","Reference":"116897"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"465410","Name":[{"lang":"en","label":"Biomarker tested in"}]}]},{"Gene":[{"Name":[{"lang":"en","label":"RUNX1 translocation partner 1"}],"Symbol":"RUNX1T1","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"1535"},{"Source":"OMIM","Reference":"133435"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317348","Name":[{"lang":"en","label":"Part of a fusion gene in"}]}]},{"Gene":[{"Name":[{"lang":"en","label":"KIT proto-oncogene, receptor tyrosine kinase"}],"Symbol":"KIT","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"6342"},{"Source":"OMIM","Reference":"164920"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"465410","Name":[{"lang":"en","label":"Biomarker tested in"}]}]}]}]}]}